About 2 results found for searched term "Naptumomab" (0.129 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24653 | Naptumomab | Others |
| Naptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid tumors such as renal cell carcinoma. | ||
| M25246 | Naptumomab estafenatox | Others |
| ABR-217620; ANYARA | ||
| Naptumomab estafenatox (ABR-217620) is a tumor targeting superantigen (TTS). Naptumomab estafenatox is a fusion protein containing an anti-5T4 antibody and a SEA/E-120 superantige. Naptumomab estafenatox can be used for the research of lung cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
